Goldblatt J C, Ferguson T B
Washington University School of Medicine, St. Louis, Missouri.
Curr Opin Cardiol. 1993 Mar;8(2):283-9. doi: 10.1097/00001573-199303000-00014.
Cardiac arrhythmia surgery has changed dramatically in the past several years, as indicated by the articles published during the past year dealing with the surgical treatment of supraventricular and ventricular arrhythmias. With the increasing use of radiofrequnecy ablation for the treatment of arrhythmias, the Maze procedure for the cure of atrial fibrillation will undoubtedly be the most commonly performed supraventricular arrhythmia procedure; the results thus far have been excellent. The use of implantable cardioverter-defibrillators as therapy for ventricular tachycardia and sudden cardiac death has allowed for more optimal selection of patients for direct ventricular tachycardia surgery, with the result that surgical mortality for curative procedures is 4%, with excellent long-term survival and freedom from arrhythmia recurrence. Finally, use of the implantable cardioverter-defibrillator as a bridge to cardiac transplantion has been examined as well, with promising intermediate-term results.
过去几年，心脏心律失常手术发生了巨大变化，过去一年发表的有关室上性和室性心律失常外科治疗的文章表明了这一点。随着射频消融在心律失常治疗中的应用日益增加，用于治疗心房颤动的迷宫手术无疑将成为最常施行的室上性心律失常手术；迄今为止，效果极佳。使用植入式心脏复律除颤器治疗室性心动过速和心源性猝死，使得在选择直接进行室性心动过速手术的患者时更为优化，结果是根治性手术的手术死亡率为4%，长期生存率高且心律失常无复发。最后，也对将植入式心脏复律除颤器用作心脏移植桥梁的情况进行了研究，中期结果很有前景。
